Abstract
The response to vitamin K antagonists (VKAs) is determined by many different factors like age, weight, height, vitamin K intake and genetic polymorphisms [1]. The proton pump inhibitors (PPIs) omeprazole and esomeprazole may enhance the effect of VKAs by inhibition of the hepatic metabolism of coumarins [2]. Some isolated cases have been reported of clinically significant elevated INRs in patients concomitantly using omeprazole and phenprocoumon, a VKA frequently used in Europe [3].Practical experience suggests an interaction between omeprazole or esomeprazole and phenprocoumon, but scientific evidence is still lacking.
| Original language | English |
|---|---|
| Pages (from-to) | 1068-1069 |
| Number of pages | 2 |
| Journal | British Journal of Clinical Pharmacology |
| Volume | 74 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2012 |
Research programs
- EMC NIHES-05-63-02 Quality
Fingerprint
Dive into the research topics of 'The effect of omeprazole and esomeprazole on the maintenance dose of phenprocoumon'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver